Thomas R. Aunins

459 total citations
9 papers, 245 citations indexed

About

Thomas R. Aunins is a scholar working on Molecular Biology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Thomas R. Aunins has authored 9 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Molecular Medicine and 2 papers in Infectious Diseases. Recurrent topics in Thomas R. Aunins's work include Antibiotic Resistance in Bacteria (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and RNA Interference and Gene Delivery (2 papers). Thomas R. Aunins is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and RNA Interference and Gene Delivery (2 papers). Thomas R. Aunins collaborates with scholars based in United States. Thomas R. Aunins's co-authors include Anushree Chatterjee, Keesha E. Erickson, Angela Jones, David M. Klaus, Shristi Shrestha, Shawn Levy, Louis Stodieck, Nripesh Prasad, Luis Zea and Antje M. K. Thamm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Frontiers in Microbiology.

In The Last Decade

Thomas R. Aunins

9 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas R. Aunins United States	8	124	71	40	34	31	9	245
Keesha E. Erickson United States	11	192 1.5×	65 0.9×	43 1.1×	76 2.2×	30 1.0×	18	315
Quyen Tran United States	8	123 1.0×	161 2.3×	73 1.8×	35 1.0×	84 2.7×	21	363
A. Fang United States	10	120 1.0×	202 2.8×	16 0.4×	12 0.4×	76 2.5×	15	361
Jillian Romsdahl United States	11	134 1.1×	94 1.3×	58 1.4×	8 0.2×	30 1.0×	16	373
L Lapchine France	9	42 0.3×	329 4.6×	32 0.8×	43 1.3×	140 4.5×	22	411
Rodney W. Ballard United States	7	184 1.5×	19 0.3×	57 1.4×	38 1.1×	4 0.1×	12	365
Simon Labarthe France	7	92 0.7×	21 0.3×	22 0.6×	15 0.4×	4 0.1×	24	272
Melanie Bähr Germany	7	83 0.7×	16 0.2×	16 0.4×	22 0.6×	6 0.2×	8	342
Stefano Pietropaoli Italy	10	197 1.6×	22 0.3×	12 0.3×	17 0.5×		11	398

Countries citing papers authored by Thomas R. Aunins

Since Specialization

Citations

This map shows the geographic impact of Thomas R. Aunins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Aunins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Aunins more than expected).

Fields of papers citing papers by Thomas R. Aunins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Aunins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Aunins. The network helps show where Thomas R. Aunins may publish in the future.

Co-authorship network of co-authors of Thomas R. Aunins

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Aunins. A scholar is included among the top collaborators of Thomas R. Aunins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Aunins. Thomas R. Aunins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Courtney, Colleen M., Nolan J. O’Connor, Thomas R. Aunins, et al.. (2023). Safety and Biodistribution of Nanoligomers Targeting the SARS-CoV-2 Genome for the Treatment of COVID-19. ACS Biomaterials Science & Engineering. 9(3). 1656–1671. 7 indexed citations

Courtney, Colleen M., Nolan J. O’Connor, Thomas R. Aunins, et al.. (2022). Nanoligomers Targeting Human miRNA for the Treatment of Severe COVID-19 Are Safe and Nontoxic in Mice. ACS Biomaterials Science & Engineering. 8(7). 3087–3106. 12 indexed citations

Aunins, Thomas R., Colleen M. Courtney, Peter B. Otoupal, et al.. (2021). Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria. Communications Biology. 4(1). 331–331. 15 indexed citations

Otoupal, Peter B., et al.. (2021). Potentiating antibiotic efficacy via perturbation of non-essential gene expression. Communications Biology. 4(1). 1267–1267. 14 indexed citations

Aunins, Thomas R., Keesha E. Erickson, & Anushree Chatterjee. (2020). Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli. Proceedings of the National Academy of Sciences. 117(48). 30699–30709. 22 indexed citations

Aunins, Thomas R., et al.. (2019). Isolating the Escherichia coli Transcriptomic Response to Superoxide Generation from Cadmium Chalcogenide Quantum Dots. ACS Biomaterials Science & Engineering. 5(9). 4206–4218. 9 indexed citations

Aunins, Thomas R., Keesha E. Erickson, Nripesh Prasad, et al.. (2018). Spaceflight Modifies Escherichia coli Gene Expression in Response to Antibiotic Exposure and Reveals Role of Oxidative Stress Response. Frontiers in Microbiology. 9. 310–310. 75 indexed citations

Aunins, Thomas R., et al.. (2018). Intracellular Hepatitis C Virus Modeling Predicts Infection Dynamics and Viral Protein Mechanisms. Journal of Virology. 92(11). 21 indexed citations

Lerma‐Ortiz, Claudia, James G. Jeffryes, Arthur J.L. Cooper, et al.. (2016). ‘Nothing of chemistry disappears in biology’: the Top 30 damage-prone endogenous metabolites. Biochemical Society Transactions. 44(3). 961–971. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact